Private Equity

Angela Sormani

Funds expected back to market in 2015

Who’s coming back to market in 2015? We’re making our best predictions.

1 min read · 15 December 2014

LP Scorecard: Southern Cross climbs highest for Washington’s funds due back to market

A Latin American fund offering from Southern Cross jumped the highest for Washington State Investment Board out of a selection of its fund managers potentially coming back to market in 2015.

2 min read · 13 October 2014

Jobs of the week: Chicago, HarbourVest, West Monroe and State Street hiring

This week there are chief investment officer, director of private equity, vice president client relations and private equity fund administrator senior associate positions for the taking.

2 min read · 07 October 2014

Navdy secures $6.5 mln seed round led by Upfront Ventures

Driving technology company Navdy has closed $6.5 million in seed round funding led by Upfront Ventures. Other investors include Ludlow Ventures, Lightbank, Promus Ventures, MESA+ I, Eniac Ventures, Wareness.io, et al.

2 min read · 02 October 2014

Centerbridge files Fund III with $5.75 bln target

Centerbridge Partners has filed a form D for its latest fund Centerbridge Capital Partners III LP specifying a target of $5.75 billion.

1 min read · 02 October 2014

Levine Leichtman Capital Partners promotes

Aaron Perlmutter has been promoted to head Levine Leichtman Capital Partners' corporate finance group. Matthew Frankel and Andrew Schwartz have been promoted to managing directors.

2 min read · 02 October 2014

Francisco Partners to acquire Vendavo

Francisco Partners is to acquire Vendavo. Based in Mountain View, Calif, Vendavo provides revenue and price optimization and management solutions for B2B mid-market and enterprise companies.

3 min read · 02 October 2014

Orchid Underwriters partners with Gryphon Investors

Orchid Underwriters, an underwriter of property insurance focusing on coastal properties, has secured backing from Gryphon Investors. CEO Michael Ray and president Brad Emmons have retained a significant ownership position in the company and will continue to lead Orchid after the closing of the transaction. Terms of the deal were not disclosed.

3 min read · 02 October 2014

Visterra closes $30 mln Series B

Biotechnology company Visterra has completed a $30 million Series B financing round. The round was co-led by new Visterra investors Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek. Existing investors Polaris Partners, Flagship Ventures, Omega Funds and Alexandria Venture Investments and a new investor Cycad Group also participated.

4 min read · 02 October 2014

Semafone secures growth backing

Semafone, a UK business specialising in fraud prevention software has secured growth capital investment from Business Growth Fund, Octopus Investments and other existing shareholders. BGF has taken a minority stake and BGF investment director Alistair Brew has been appointed to the board with investment manager Will Gresty joining as observer to the board.

3 min read · 02 October 2014

Showing 1 to 10 of 5,354 results